Testing effectiveness (Phase 2)Study completedNCT01414205
What this trial is testing
A Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GAGE)
Who this might be right for
Lymphocytic Leukemia, Chronic
Genentech, Inc. 80